Sign up to save your podcasts
Or
Share Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A
Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.
See omnystudio.com/listener for privacy information.
View all episodes
By Bloomberg
4.6
1616 ratings
Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.
See omnystudio.com/listener for privacy information.
More shows like Bloomberg Talks
View all
Exchanges
952 Listeners
Bloomberg Intelligence
404 Listeners
Bloomberg Surveillance
1,173 Listeners
Masters in Business
2,170 Listeners
Odd Lots
1,938 Listeners
Bloomberg Businessweek
418 Listeners
Foundering
969 Listeners
Capital Allocators – Inside the Institutional Investment Industry
793 Listeners
Trillions
193 Listeners
Making Sense
61 Listeners
Value Investing with Legends
211 Listeners
Thoughts on the Market
1,299 Listeners
Here's Why
60 Listeners
Out of Office
30 Listeners
Wall Street Week
65 Listeners
The Memo by Howard Marks
453 Listeners
Listen to the Story
4 Listeners
Into the Metaverse
58 Listeners
Bedrock, USA
233 Listeners
Zero: The Climate Race
229 Listeners
Bloomberg Tech
62 Listeners
Bloomberg Daybreak: US Edition
82 Listeners
The Markets
79 Listeners
Bloomberg News Now
72 Listeners
The Deal with Alex Rodriguez and Jason Kelly
85 Listeners
Money Stuff: The Podcast
393 Listeners
In the City
12 Listeners
Bloomberg Opinion
8 Listeners
The Cable
2 Listeners
IVF Disrupted: The Kindbody Story
72 Listeners